1
|
Molecular evolution of antibody cross-reactivity for two subtypes of type A botulinum neurotoxin.
|
Nat Biotechnol
|
2006
|
2.66
|
2
|
Influence of affinity and antigen internalization on the uptake and penetration of Anti-HER2 antibodies in solid tumors.
|
Cancer Res
|
2011
|
1.62
|
3
|
Antibody protection against botulinum neurotoxin intoxication in mice.
|
Infect Immun
|
2009
|
1.43
|
4
|
Extraction and inhibition of enzymatic activity of botulinum neurotoxins/A1, /A2, and /A3 by a panel of monoclonal anti-BoNT/A antibodies.
|
PLoS One
|
2009
|
1.35
|
5
|
Regulation of antibody-dependent cellular cytotoxicity by IgG intrinsic and apparent affinity for target antigen.
|
J Immunol
|
2007
|
1.32
|
6
|
Extraction of BoNT/A, /B, /E, and /F with a single, high affinity monoclonal antibody for detection of botulinum neurotoxin by Endopep-MS.
|
PLoS One
|
2010
|
1.28
|
7
|
Mouse and human lung fibroblasts regulate dendritic cell trafficking, airway inflammation, and fibrosis through integrin αvβ8-mediated activation of TGF-β.
|
J Clin Invest
|
2011
|
1.25
|
8
|
A single-domain llama antibody potently inhibits the enzymatic activity of botulinum neurotoxin by binding to the non-catalytic alpha-exosite binding region.
|
J Mol Biol
|
2010
|
1.10
|
9
|
Isolation of scFvs to in vitro produced extracellular domains of EGFR family members.
|
Cancer Biother Radiopharm
|
2005
|
1.06
|
10
|
Using phage display to select antibodies recognizing post-translational modifications independently of sequence context.
|
Mol Cell Proteomics
|
2006
|
1.00
|
11
|
Yeast mating for combinatorial Fab library generation and surface display.
|
FEBS Lett
|
2004
|
0.99
|
12
|
Molecular architecture of botulinum neurotoxin E revealed by single particle electron microscopy.
|
J Biol Chem
|
2007
|
0.98
|
13
|
Impact of intrinsic affinity on functional binding and biological activity of EGFR antibodies.
|
Mol Cancer Ther
|
2012
|
0.92
|
14
|
Tumor detection by imaging proteolytic activity.
|
Cancer Res
|
2010
|
0.92
|
15
|
Antibodies in proteomics II: screening, high-throughput characterization and downstream applications.
|
Trends Biotechnol
|
2003
|
0.90
|
16
|
Affinity maturation to improve human monoclonal antibody neutralization potency and breadth against hepatitis C virus.
|
J Biol Chem
|
2011
|
0.88
|
17
|
Enzyme-amplified protein microarray and a fluidic renewable surface fluorescence immunoassay for botulinum neurotoxin detection using high-affinity recombinant antibodies.
|
Anal Chim Acta
|
2006
|
0.88
|
18
|
Quantum dot immunoassays in renewable surface column and 96-well plate formats for the fluorescence detection of botulinum neurotoxin using high-affinity antibodies.
|
Biosens Bioelectron
|
2009
|
0.87
|
19
|
Identification of the SV2 protein receptor-binding site of botulinum neurotoxin type E.
|
Biochem J
|
2013
|
0.86
|
20
|
Antibodies in proteomics I: generating antibodies.
|
Trends Biotechnol
|
2003
|
0.86
|
21
|
Extraction and inhibition of enzymatic activity of botulinum neurotoxins /B1, /B2, /B3, /B4, and /B5 by a panel of monoclonal anti-BoNT/B antibodies.
|
BMC Biochem
|
2011
|
0.85
|
22
|
Renewable surface fluorescence sandwich immunoassay biosensor for rapid sensitive botulinum toxin detection in an automated fluidic format.
|
Analyst
|
2009
|
0.84
|
23
|
Simultaneous and sensitive detection of six serotypes of botulinum neurotoxin using enzyme-linked immunosorbent assay-based protein antibody microarrays.
|
Anal Biochem
|
2012
|
0.82
|
24
|
Rapid multiplexed flow cytometric assay for botulinum neurotoxin detection using an automated fluidic microbead-trapping flow cell for enhanced sensitivity.
|
Anal Chem
|
2009
|
0.81
|
25
|
RNA aptasensor for rapid detection of natively folded type A botulinum neurotoxin.
|
Talanta
|
2013
|
0.80
|
26
|
Development of human single-chain antibodies against SARS-associated coronavirus.
|
Intervirology
|
2008
|
0.79
|
27
|
Development of an ELISA microarray assay for the sensitive and simultaneous detection of ten biodefense toxins.
|
Analyst
|
2014
|
0.78
|